Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Yano

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2025
[Clinical Features and Management of Pseudomyxoma Peritonei Appendiceal Origin]Yoshimasa Gohda, Tomomichi Kiyomatsu, Hiroshi Takeuchi, et al.
World Journal of Surgical Oncology|June 15, 2019
Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three casesKyoji Ito, Nobuyuki Takemura, Fuyuki Inagaki, et al.
Biomolecules|April 30, 2021
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 ReceptorPramisha Adhikari, Bing Xie, Ana Semeano, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
A subtle structural modification of a synthetic cannabinoid receptor agonist drastically increases its efficacy at the CB1 receptorHideaki Yano, Rezvan Chitsazi, Christopher Lucaj, et al.
The Journal of Biological Chemistry|September 18, 2009
Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonistsDenis Sohy, Hideaki Yano, Patricia de Nadai, et al.
ACS Chemical Neuroscience|October 17, 2023
Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 ReceptorHideaki Yano, Rezvan Chitsazi, Christopher Lucaj, et al.
ACS Pharmacology & Translational Science|February 19, 2019
Novel and Potent Dopamine D<sub>2</sub> Receptor Go-Protein Biased AgonistsAlessandro Bonifazi, Hideaki Yano, Adrian M Guerrero, et al.
Annals of Gastroenterological Surgery|September 9, 2025
New National Network of Experts (Japan Pelvic Exenteration Network: J-PEN) Formed in a Bid to Improve Outcomes of Pelvic Exenteration in JapanHideaki Yano, Alex Mirnezami, Masataka Ikeda, et al.
Case Reports in Medicine|February 20, 2014
Acinar cell carcinoma of the pancreas with colon involvementNaoki Asayama, Yasushi Kojima, Tomonori Aoki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Prognostic significance of 18q loss of heterzygosity in microsatellite-stable colorectal cancerToshiaki Watanabe, Takashi Kobunai, Yoko Yamamoto, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2025
[Clinical Features and Management of Pseudomyxoma Peritonei Appendiceal Origin]Yoshimasa Gohda, Tomomichi Kiyomatsu, Hiroshi Takeuchi, et al.
World Journal of Surgical Oncology|June 15, 2019
Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three casesKyoji Ito, Nobuyuki Takemura, Fuyuki Inagaki, et al.
Biomolecules|April 30, 2021
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 ReceptorPramisha Adhikari, Bing Xie, Ana Semeano, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
A subtle structural modification of a synthetic cannabinoid receptor agonist drastically increases its efficacy at the CB1 receptorHideaki Yano, Rezvan Chitsazi, Christopher Lucaj, et al.
The Journal of Biological Chemistry|September 18, 2009
Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonistsDenis Sohy, Hideaki Yano, Patricia de Nadai, et al.
ACS Chemical Neuroscience|October 17, 2023
Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 ReceptorHideaki Yano, Rezvan Chitsazi, Christopher Lucaj, et al.
ACS Pharmacology & Translational Science|February 19, 2019
Novel and Potent Dopamine D<sub>2</sub> Receptor Go-Protein Biased AgonistsAlessandro Bonifazi, Hideaki Yano, Adrian M Guerrero, et al.
Annals of Gastroenterological Surgery|September 9, 2025
New National Network of Experts (Japan Pelvic Exenteration Network: J-PEN) Formed in a Bid to Improve Outcomes of Pelvic Exenteration in JapanHideaki Yano, Alex Mirnezami, Masataka Ikeda, et al.
Case Reports in Medicine|February 20, 2014
Acinar cell carcinoma of the pancreas with colon involvementNaoki Asayama, Yasushi Kojima, Tomonori Aoki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Prognostic significance of 18q loss of heterzygosity in microsatellite-stable colorectal cancerToshiaki Watanabe, Takashi Kobunai, Yoko Yamamoto, et al.
Pageof 9